Ameriprise Financial Inc Novartis Ag Transaction History

Ameriprise Financial Inc

$364 Billion
Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Novartis Ag stock. As of the latest transaction made, Ameriprise Financial Inc holds 447,674 shares of NVS stock, worth $49.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

447,674

Previous 429,542 4.22%

Holding current value

$49.5 Million

Previous $41.5 Million 14.71%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $1.68 Million - $1.95 Million	18,132 Added 4.22%	447,674 $47.7 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $6.18 Million - $7.03 Million	64,829 Added 17.78%	429,542 $41.5 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $1.14 Million - $1.25 Million	-12,336 Reduced 3.27%	364,713 $36.8 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $4.39 Million - $4.87 Million	-46,338 Reduced 10.94%	377,049 $38.4 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $891,152 - $1.01 Million	9,632 Added 2.33%	423,387 $42.7 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $12.4 Million - $14.3 Million	-154,542 Reduced 27.19%	413,755 $38.1 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $5.77 Million - $7.07 Million	-76,390 Reduced 11.85%	568,297 $51.6 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $4.93 Million - $5.77 Million	-66,093 Reduced 9.3%	644,687 $49 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $61.7 Million - $71.8 Million	-766,267 Reduced 51.88%	710,780 $60.1 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $10.3 Million - $11.7 Million	129,010 Added 9.57%	1,477,047 $130 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $5.34 Million - $5.9 Million	-66,951 Reduced 4.73%	1,348,037 $118 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $25.7 Million - $29.9 Million	-313,799 Reduced 18.15%	1,414,988 $116 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $308,483 - $340,728	3,619 Added 0.21%	1,728,787 $158 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $2.34 Million - $2.76 Million	-27,982 Reduced 1.6%	1,725,168 $147 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $49.8 Million - $60.2 Million	637,848 Added 57.19%	1,753,150 $166 Million
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $4.4 Million - $4.87 Million	-53,513 Reduced 4.58%	1,115,302 $97.1 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $3.08 Million - $3.46 Million	-38,000 Reduced 3.15%	1,168,815 $102 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $251,514 - $352,376	-3,559 Reduced 0.29%	1,206,815 $99.4 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $15.5 Million - $17.5 Million	183,560 Added 17.88%	1,210,374 $115 Million
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $2.42 Million - $2.67 Million	-28,301 Reduced 2.68%	1,026,814 $89.2 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $207,274 - $255,107	-2,749 Reduced 0.26%	1,055,115 $96.3 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $841,399 - $962,381	11,171 Added 1.07%	1,057,864 $102 Million
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $4.87 Million - $5.42 Million	66,100 Added 6.74%	1,046,693 $89.8 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $3.52 Million - $4.07 Million	52,616 Added 5.67%	980,593 $106 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $1.53 Million - $1.73 Million	23,578 Added 2.61%	927,977 $70.1 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $3.78 Million - $4.52 Million	-53,707 Reduced 5.61%	904,399 $73.2 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $1.59 Million - $1.71 Million	-22,017 Reduced 2.25%	958,106 $80.4 Million
Q3 2017 Nov 07, 2017	BUY	$74.14 - $77.27 $72.7 Million - $75.7 Million	980,123	980,123 $84.1 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Novartis Ag Transaction History